• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄和性别对有主观记忆主诉者的血浆 NFL 和 t-Tau 轨迹有影响:一项 3 年随访研究。

Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study.

机构信息

Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, F-75013, Paris, France.

Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56125, Pisa, Italy.

出版信息

Alzheimers Res Ther. 2020 Nov 12;12(1):147. doi: 10.1186/s13195-020-00704-4.

DOI:10.1186/s13195-020-00704-4
PMID:33183357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7663867/
Abstract

BACKGROUND

Plasma neurofilament light (NFL) and total Tau (t-Tau) proteins are candidate biomarkers for early stages of Alzheimer's disease (AD). The impact of biological factors on their plasma concentrations in individuals with subjective memory complaints (SMC) has been poorly explored. We longitudinally investigate the effect of sex, age, APOE ε4 allele, comorbidities, brain amyloid-β (Aβ) burden, and cognitive scores on plasma NFL and t-Tau concentrations in cognitively healthy individuals with SMC, a condition associated with AD development.

METHODS

Three hundred sixteen and 79 individuals, respectively, have baseline and three-time point assessments (at baseline, 1-year, and 3-year follow-up) of the two biomarkers. Plasma biomarkers were measured with an ultrasensitive assay in a mono-center cohort (INSIGHT-preAD study).

RESULTS

We show an effect of age on plasma NFL, with women having a higher increase of plasma t-Tau concentrations compared to men, over time. The APOE ε4 allele does not affect the biomarker concentrations while plasma vitamin B12 deficiency is associated with higher plasma t-Tau concentrations. Both biomarkers are correlated and increase over time. Baseline NFL is related to the rate of Aβ deposition at 2-year follow-up in the left-posterior cingulate and the inferior parietal gyri. Baseline plasma NFL and the rate of change of plasma t-Tau are inversely associated with cognitive score.

CONCLUSION

We find that plasma NFL and t-Tau longitudinal trajectories are affected by age and female sex, respectively, in SMC individuals. Exploring the influence of biological variables on AD biomarkers is crucial for their clinical validation in blood.

摘要

背景

血浆神经丝轻链(NFL)和总 Tau(t-Tau)蛋白是阿尔茨海默病(AD)早期的候选生物标志物。生物因素对有主观记忆主诉(SMC)的个体血浆浓度的影响尚未得到充分研究。我们纵向研究了性别、年龄、APOE ε4 等位基因、合并症、脑β淀粉样蛋白(Aβ)负担和认知评分对认知健康个体 SMC 中血浆 NFL 和 t-Tau 浓度的影响,SMC 与 AD 发展相关。

方法

分别有 316 名和 79 名个体进行了基线和三次时间点(基线、1 年和 3 年随访)的这两种生物标志物评估。在单中心队列(INSIGHT-preAD 研究)中使用超敏测定法测量了血浆生物标志物。

结果

我们显示了年龄对血浆 NFL 的影响,随着时间的推移,女性血浆 t-Tau 浓度的增加高于男性。APOE ε4 等位基因不影响生物标志物浓度,而血浆维生素 B12 缺乏与较高的血浆 t-Tau 浓度相关。两种生物标志物均相关且随时间增加。基线 NFL 与 2 年随访时左后扣带回和下顶叶的 Aβ 沉积率相关。基线血浆 NFL 和血浆 t-Tau 变化率与认知评分呈负相关。

结论

我们发现,在 SMC 个体中,血浆 NFL 和 t-Tau 的纵向轨迹分别受年龄和女性性别影响。探索生物变量对 AD 生物标志物的影响对于它们在血液中的临床验证至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1490/7663867/e7b5e3016ecb/13195_2020_704_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1490/7663867/691cdf3ec27b/13195_2020_704_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1490/7663867/e7b5e3016ecb/13195_2020_704_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1490/7663867/691cdf3ec27b/13195_2020_704_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1490/7663867/e7b5e3016ecb/13195_2020_704_Fig2_HTML.jpg

相似文献

1
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study.年龄和性别对有主观记忆主诉者的血浆 NFL 和 t-Tau 轨迹有影响:一项 3 年随访研究。
Alzheimers Res Ther. 2020 Nov 12;12(1):147. doi: 10.1186/s13195-020-00704-4.
2
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.阿尔茨海默病患者纵向血浆神经丝轻链与神经退行性变的关系。
JAMA Neurol. 2019 Jul 1;76(7):791-799. doi: 10.1001/jamaneurol.2019.0765.
3
Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.基于血浆生物标志物预测轻度认知障碍患者的纵向认知下降和阿尔茨海默病转化。
Cells. 2024 Jun 22;13(13):1085. doi: 10.3390/cells13131085.
4
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.血浆神经丝轻链与阿尔茨海默病影像学生物标志物的阶段特异性关联。
Brain. 2020 Dec 1;143(12):3793-3804. doi: 10.1093/brain/awaa342.
5
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.血浆神经丝轻链作为主观认知下降和轻度认知障碍的阿尔茨海默病生物标志物。
J Neurol. 2022 Aug;269(8):4270-4280. doi: 10.1007/s00415-022-11055-5. Epub 2022 Mar 14.
6
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.阿尔茨海默病连续体中的血浆 Aβ42/40 比值、p-tau181、GFAP 和 NfL:AIBL 队列的横断面和纵向研究。
Alzheimers Dement. 2023 Apr;19(4):1117-1134. doi: 10.1002/alz.12724. Epub 2022 Jul 21.
7
Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's disease signature regions and predicted future tau deposition.血浆神经丝轻链升高与阿尔茨海默病特征区域的多模态神经影像学特征相关,并可预测未来的tau 沉积。
BMC Neurol. 2024 Jul 6;24(1):236. doi: 10.1186/s12883-024-03728-7.
8
Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.血浆 tau 蛋白、神经丝轻链和淀粉样 β 水平与痴呆风险:一项基于人群的队列研究。
Brain. 2020 Apr 1;143(4):1220-1232. doi: 10.1093/brain/awaa054.
9
Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease.血浆 tau 与阿尔茨海默病风险人群的基底前脑萎缩率相关。
Neurology. 2020 Jan 7;94(1):e30-e41. doi: 10.1212/WNL.0000000000008696. Epub 2019 Dec 4.
10
The impact of kidney function on Alzheimer's disease blood biomarkers: implications for predicting amyloid-β positivity.肾功能对阿尔茨海默病血液生物标志物的影响:对预测淀粉样蛋白-β阳性的意义。
Alzheimers Res Ther. 2025 Feb 19;17(1):48. doi: 10.1186/s13195-025-01692-z.

引用本文的文献

1
Plasma neurofilament light reflects more severe manifestation of Alzheimer's disease in men.血浆神经丝轻链反映出男性阿尔茨海默病更严重的表现。
Mol Psychiatry. 2025 Aug 12. doi: 10.1038/s41380-025-03149-z.
2
Diagnostic value of fluid-based non-amyloid biomarkers for Alzheimer's disease and related dementias in a clinic-based cohort from South Asia.基于液体的非淀粉样生物标志物对南亚临床队列中阿尔茨海默病及相关痴呆症的诊断价值
Alzheimers Dement (Amst). 2025 May 27;17(2):e70129. doi: 10.1002/dad2.70129. eCollection 2025 Apr-Jun.
3
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis.

本文引用的文献

1
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases.不同临床应用情境下的血液神经丝轻链蛋白在神经退行性疾病谱中的应用。
Mol Neurobiol. 2020 Nov;57(11):4667-4691. doi: 10.1007/s12035-020-02035-9. Epub 2020 Aug 9.
2
Sex differences in Alzheimer's-related Tau biomarkers and a mediating effect of testosterone.阿尔茨海默病相关 Tau 生物标志物的性别差异及睾酮的中介作用。
Biol Sex Differ. 2020 Jun 19;11(1):33. doi: 10.1186/s13293-020-00310-x.
3
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.
临床前阿尔茨海默病纵向tau正电子发射断层扫描中的性别差异:一项荟萃分析。
JAMA Neurol. 2025 Mar 3;82(4):364-75. doi: 10.1001/jamaneurol.2025.0013.
4
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization.用于生物标志物分类的常见阿尔茨海默病研究本体(CADRO)。
Alzheimers Dement (N Y). 2025 Feb 11;11(1):e70050. doi: 10.1002/trc2.70050. eCollection 2025 Jan-Mar.
5
Serum NFL and neuropsychological performance over ∼8 years in women with and without HIV: a longitudinal repeated measures study.有和未感染艾滋病毒女性约8年期间的血清神经丝轻链蛋白水平与神经心理表现:一项纵向重复测量研究
EClinicalMedicine. 2025 Jan 21;80:103052. doi: 10.1016/j.eclinm.2024.103052. eCollection 2025 Feb.
6
Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use.穿透噪音:阿尔茨海默病血浆生物标志物用于常规临床应用的叙述性综述
J Prev Alzheimers Dis. 2025 Apr;12(4):100056. doi: 10.1016/j.tjpad.2024.100056. Epub 2025 Jan 14.
7
Neurofilament light and cognition in community-dwelling non-Hispanic Blacks.社区居住的非西班牙裔黑人的神经丝轻链与认知。
J Alzheimers Dis. 2024 Nov;102(1):60-66. doi: 10.1177/13872877241283693. Epub 2024 Oct 20.
8
Cumulative Socioeconomic Status Risk is Associated With Greater Increase in Serum Neurofilament Light Chain Levels Among Middle-Aged Black Adults.累积社会经济地位风险与中年黑人成年人血清神经丝轻链水平的更大升高有关。
J Gerontol A Biol Sci Med Sci. 2024 Dec 11;80(1). doi: 10.1093/gerona/glae253.
9
Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and Prognostics.阿尔茨海默病的血液生物标志物:推进非侵入性诊断和预后评估。
Int J Mol Sci. 2024 Oct 10;25(20):10911. doi: 10.3390/ijms252010911.
10
Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study.阿尔茨海默病血浆生物标志物在高龄老人中的预后价值:一项基于初级保健的前瞻性研究。
Lancet Reg Health Eur. 2024 Aug 16;45:101030. doi: 10.1016/j.lanepe.2024.101030. eCollection 2024 Oct.
基于生物标志物的神经退行性疾病谱的诊断标准的建立。
Expert Rev Mol Diagn. 2020 Apr;20(4):421-441. doi: 10.1080/14737159.2020.1731306. Epub 2020 Feb 27.
4
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.脑脊液神经丝轻链蛋白在神经病学中的诊断价值:一项系统评价和荟萃分析
JAMA Neurol. 2019 Sep 1;76(9):1035-1048. doi: 10.1001/jamaneurol.2019.1534.
5
Blood-based diagnostics of Alzheimer's disease.阿尔茨海默病的基于血液的诊断。
Expert Rev Mol Diagn. 2019 Jul;19(7):613-621. doi: 10.1080/14737159.2019.1626719. Epub 2019 Jun 8.
6
A frontline defense against neurodegenerative diseases:the development of early disease detection methods.对抗神经退行性疾病的前沿防线:早期疾病检测方法的发展
Expert Rev Mol Diagn. 2019 Jul;19(7):559-563. doi: 10.1080/14737159.2019.1627202. Epub 2019 Jun 10.
7
Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease.无症状阿尔茨海默病高危个体的默认模式网络轨迹差异。
Alzheimers Dement. 2019 Jul;15(7):940-950. doi: 10.1016/j.jalz.2019.03.006. Epub 2019 May 18.
8
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.阿尔茨海默病患者纵向血浆神经丝轻链与神经退行性变的关系。
JAMA Neurol. 2019 Jul 1;76(7):791-799. doi: 10.1001/jamaneurol.2019.0765.
9
Neurofilament light chain as a biomarker in neurological disorders.神经丝轻链作为神经紊乱的生物标志物。
J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):870-881. doi: 10.1136/jnnp-2018-320106. Epub 2019 Apr 9.
10
Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes.评估血浆总 tau 水平作为痴呆症及相关表型的预测生物标志物。
JAMA Neurol. 2019 May 1;76(5):598-606. doi: 10.1001/jamaneurol.2018.4666.